FLINT, Mich., Nov. 26, 2018 /PRNewswire/ -- Diplomat
Pharmacy, Inc. (NYSE: DPLO), is now shipping
temperature-sensitive medication in ClimaCell™ coolers from
TemperPack.
ClimaCell coolers are fully recyclable at curbside and insulated
with renewable materials that can be recycled wherever plastic bags
are accepted. Diplomat previously used expanded polystyrene (EPS)
foam coolers.
Diplomat's efforts will help divert more than five tons of
plastic from landfills every week by moving away from EPS foam,
according to TemperPack. Per their analysis, ClimaCell coolers
require 94 percent less energy to manufacture — meaning reduced
carbon emissions.
The move reflects Diplomat's commitment to protecting the
environment while ensuring patient safety, said Chairman and CEO
Brian Griffin.
"Switching to ClimaCell not only reduces Diplomat's carbon
footprint; it's also a reflection of our steadfast commitment to
patients," Griffin said. "It's difficult to dispose of EPS foam
responsibly, and our patients have already expressed their
excitement about reducing the amount of plastic heading to
landfills. This new packaging allows us to be better stewards of
the environment while keeping specialty medications at a stable
temperature."
ClimaCell coolers meet International Safe Transit Association
standards — meaning they will keep medication at a safe temperature
even in extreme weather conditions.
TemperPack cofounder James McGoff
said: "Our healthcare system relies on petroleum-based plastics —
especially EPS foam. Patients don't think this is sustainable, and
neither do we. ClimaCell is the first in a series of high-tech,
plant-based technologies that will empower companies like Diplomat
to continue improving human health without compromising
environmental health. We are honored and excited to support such an
innovative company."
To learn more about Diplomat, visit diplomat.is.
Forward-Looking Statements
This press release contains
forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements give current expectations or forecasts
of future events or our future financial or operating performance.
The forward-looking statements contained in this press release are
based on management's good-faith belief and reasonable judgment
based on current information. These statements are qualified by
important risks and uncertainties, many of which are beyond our
control, that could cause our actual results to differ materially
from those forecasted or indicated by such forward-looking
statements. For a discussion of such risks and uncertainties, you
should review Diplomat's filings with the Securities and Exchange
Commission, including "Risk Factors" in Diplomat's Annual Report on
Form 10-K for the year ended Dec. 31,
2017, and in subsequent reports filed with or furnished to
the Securities and Exchange Commission. Except as may be required
by any applicable laws, Diplomat assumes no obligation to publicly
update such forward-looking statements, which are made as of the
date hereof or the earlier date specified herein, whether as a
result of new information, future developments, or otherwise.
About Diplomat
Diplomat (NYSE: DPLO) is the nation's
largest independent provider of specialty pharmacy and infusion
services. Diplomat helps people with complex and chronic health
conditions in all 50 states, partnering with payers, providers,
hospitals, manufacturers, and more. Rooted in this patient care
expertise, Diplomat also serves payers through CastiaRx, a leading
specialty benefit manager, and offers tailored solutions for
healthcare innovators through EnvoyHealth. Diplomat opened its
doors in 1975 as a neighborhood pharmacy with one essential tenet:
"Take good care of patients and the rest falls into place." Today,
that tradition continues — always focused on improving patient
care. For more information, visit diplomat.is.
About TemperPack
Founded in 2015, TemperPack solves
thermal packaging problems through sustainable design. The company
was born out of a desire to reduce the amount of unsustainable
packaging that correlated with the rising world of e-commerce
delivery. They specialize in bringing custom solutions for clients
to scale in the perishable food and life sciences industries.
Today, TemperPack operates two facilities in Virginia and Nevada and is rapidly expanding its reach in
the perishable and cold-chain shipping market, all with the goal of
reducing the amount of packaging that ends up in landfills. For
more information, visit temperpack.com.
CONTACT:
Elizabeth
Carr, Corporate Communications Manager
810.768.9871 | press@diplomat.is
View original content to download
multimedia:http://www.prnewswire.com/news-releases/diplomat-switches-to-fully-recyclable-packaging-for-temperature-sensitive-medication-300755342.html
SOURCE Diplomat Pharmacy, Inc.